-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Pyxis Oncology, Raises Price Target to $19

Benzinga·09/09/2026 17:37:16
Listen to the news
Wells Fargo analyst Derek Archila maintains Pyxis Oncology (NASDAQ:PYXS) with a Overweight and raises the price target from $12 to $19.